Israel is expected to soon approve the coronavirus vaccine for children aged 5 to 11 years old, after an expert advisory committee to the FDA in the United States overwhelmingly recommended authorizing emergency use of a modified dose of the Pfizer vaccine for younger children.  What will the rollout look like?

KAN Naomi Segal spoke with Prof. Cyrille Cohen, head of the laboratory of immunotherapy at Bar-Ilan University, about the decision of the FDA expert advisory committee recommending the coronavirus vaccine for children; and the deliberations now getting underway in Israel.